Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Disease, ASCVD”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Not applicableStudy completedNCT07141914
What this trial is testing

A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World

Who this might be right for
OverweightObesityHeart Failure (HF)+2 more
Novo Nordisk A/S 285,327
Not applicableUnknownNCT03606824
What this trial is testing

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

Who this might be right for
DyslipidemiaSubclinical hypothyroïdismStatin+1 more
Shaochun.Li 248
Large-scale testing (Phase 3)Study completedNCT03337308
What this trial is testing

A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy

Who this might be right for
Hyperlipidemias
Esperion Therapeutics, Inc. 382
Not applicableStudy completedNCT03427307
What this trial is testing

Serum Level of Lipopolysaccharide-binding Protein (LBP) and Atherosclerosis in Hemodialysis Patients

Who this might be right for
Systemic Inflammatory Response Syndrome
Tungs' Taichung Metroharbour Hospital 360
Not applicableLooking for participantsNCT07542860
What this trial is testing

Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Secondary PreventionCardiovascular Diseases
Peking University First Hospital 5,448
Not applicableLooking for participantsNCT05879913
What this trial is testing

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Who this might be right for
Prostate Cancer
Indiana University 100
Not applicableStudy completedNCT03911284
What this trial is testing

The Learning Registry

Who this might be right for
Atherosclerotic Cardiovascular Disease
Duke University 2,000
Not applicableUnknownNCT06316453
What this trial is testing

Prospective Assessment of Atherosclerotic Cardiovascular Disease (ASCVD) Risk

Who this might be right for
Atherosclerotic Cardiovascular Diseases (ASCVD)
Advanced Education & Research Center 3,513
Not applicableStudy completedNCT07196280
What this trial is testing

Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Benign Prostatic Hypertrophy (BPH)
Chinese PLA General Hospital 10,000
Not applicableUnknownNCT03868332
What this trial is testing

Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases
Assiut University 80
Not applicableNot Yet RecruitingNCT07524101
What this trial is testing

Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

Who this might be right for
Renal InsufficiencyAtherosclerosisDyslipidemia+2 more
Yonsei University 1,952
Not applicableLooking for participantsNCT06960902
What this trial is testing

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)

Who this might be right for
Familial HypercholesterolemiasAtherosclerotic Cardiovascular Disease (ASCVD)
Nantes University Hospital 600
Large-scale testing (Phase 3)Study completedNCT03399370
What this trial is testing

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

Who this might be right for
ASCVDElevated Cholesterol
The Medicines Company 1,561
Post-approval studies (Phase 4)Study completedNCT03474562
What this trial is testing

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Who this might be right for
ASCVDImpaired Fasting GlucoseHypertension
Yuhan Corporation 100
Not applicableAvailableNCT07000695
What this trial is testing

Managed Access Programs for TQJ230, Pelacarsen

Who this might be right for
Atherosclerotic Cardiovascular Disease, ASCVD
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT05142722
What this trial is testing

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

Who this might be right for
DyslipidemiasHigh CholesterolHypercholesterolemia+2 more
NewAmsterdam Pharma 2,530
Not applicableStudy completedNCT05755373
What this trial is testing

A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)
Novo Nordisk A/S 602
Testing effectiveness (Phase 2)Looking for participantsNCT07327840
What this trial is testing

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Who this might be right for
Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD. 204
Testing effectiveness (Phase 2)Looking for participantsNCT07235046
What this trial is testing

DII235 in Adults With Elevated Lipoprotein(a)

Who this might be right for
Lipoprotein Disorder
Novartis Pharmaceuticals 200
Post-approval studies (Phase 4)Active Not RecruitingNCT06249165
What this trial is testing

VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Duke University 130
Load More Results